{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:33:10Z","timestamp":1768984390124,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00393-024-01594-9","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T13:25:53Z","timestamp":1733145953000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reaktive Arthritis","Reactive arthritis"],"prefix":"10.1007","volume":"84","author":[{"given":"Markus","family":"Rihl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens G.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"1594_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/rhe1.1969.15.issue-1-4.32","volume":"15","author":"P Ahvonen","year":"1969","unstructured":"Ahvonen\u00a0P, Sievers\u00a0K, Aho\u00a0K (1969) Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand 15:232\u2013253","journal-title":"Acta Rheumatol Scand"},{"key":"1594_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(73)93109-7","volume":"2","author":"K Aho","year":"1973","unstructured":"Aho\u00a0K, Ahvonen\u00a0P, Lassus\u00a0A et\u00a0al (1973) HL\u2011A antigen 27 and reactive arthritis. Lancet 2:157\u2013161","journal-title":"Lancet"},{"key":"1594_CR3","first-page":"2185","volume":"27","author":"J Braun","year":"2000","unstructured":"Braun\u00a0J, Kingsley\u00a0G, van der Heijde\u00a0D et\u00a0al (2000) On the difficulties of establishing a\u00a0consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a\u00a0questionnaire prepared for the 4th\u00a0International Workshop on Reactive Arthritis, Berlin, Germany, July 3\u20136, 1999. J\u00a0Rheumatol 27:2185\u20132192","journal-title":"J Rheumatol"},{"key":"1594_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit\u00a0M, van der Heijde\u00a0D, Landew\u00e9\u00a0R et\u00a0al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritisand for spondyloarthritis in general. Ann Rheum Dis 70:25\u201331","journal-title":"Ann Rheum Dis"},{"key":"1594_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11926-021-01018-6","volume":"23","author":"H Zeidler","year":"2021","unstructured":"Zeidler\u00a0H, Hudson\u00a0AP (2021) Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep 23:53","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"1594_CR6","doi-asserted-by":"publisher","first-page":"103287","DOI":"10.1016\/j.autrev.2023.103287","volume":"22","author":"JW Cohen Tervaert","year":"2023","unstructured":"Cohen Tervaert\u00a0JW, Martinez-Lavin\u00a0M, Jara\u00a0LJ et\u00a0al (2023) Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023. Autoimmun Rev 22(5):103287","journal-title":"Autoimmun Rev"},{"key":"1594_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0889-857X(02)00082-0","volume":"29","author":"D Yu","year":"2003","unstructured":"Yu\u00a0D, Kuipers\u00a0JG (2003) Role of bacteria and HLA-B27 in the pathogenesis of reactive arthritis. Rheum Dis Clin North Am 29:21\u201336","journal-title":"Rheum Dis Clin North Am"},{"key":"1594_CR8","first-page":"115","volume":"21","author":"TK Kvien","year":"1994","unstructured":"Kvien\u00a0TK, Glennas\u00a0A, Melby\u00a0G et\u00a0al (1994) Reactive arthritis: incidence, triggering agents and clinical presentation. J\u00a0Rheumatol 21:115\u2013122","journal-title":"J Rheumatol"},{"key":"1594_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.berh.2004.05.008","volume":"18","author":"A Toivanen","year":"2004","unstructured":"Toivanen\u00a0A, Toivanen\u00a0P (2004) Reactive arthritis. Best Pract Res Clin Rheumatol 18:689\u2013703","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1594_CR10","first-page":"218","volume":"34","author":"H Zeidler","year":"2022","unstructured":"Zeidler\u00a0H, Hudson\u00a0AP (2022) Quo vadis reactive arthritis? Curr Opin Rheumatol 34(4):218\u2013224","journal-title":"Curr Opin Rheumatol"},{"key":"1594_CR11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1186\/1471-2458-14-1203","volume":"14","author":"J Keithlin","year":"2014","unstructured":"Keithlin\u00a0J, Sargeant\u00a0J, Thomas\u00a0MK et\u00a0al (2014) Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health 14:1203","journal-title":"BMC Public Health"},{"key":"1594_CR12","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1136\/annrheumdis-2013-203431","volume":"73","author":"M Vasala","year":"2014","unstructured":"Vasala\u00a0M, Hallanvuo\u00a0S, Ruuska\u00a0P et\u00a0al (2014) High frequency of reactive arthritis in adults after Yersinia pseudotuberculosis O:1 outbreak caused by contaminated grated carrots. Ann Rheum Dis 73:1793\u20131796","journal-title":"Ann Rheum Dis"},{"key":"1594_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1756-185X.2009.01446.x","volume":"13","author":"MB Owlia","year":"2010","unstructured":"Owlia\u00a0MB, Eley\u00a0AR (2010) Is the role of Chlamydia trachomatis underestimated in patients with suspected reactive arthritis? Int J Rheum Dis 13:27\u201338","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"1594_CR14","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1007\/s10067-016-3364-0","volume":"35","author":"HJ Denison","year":"2016","unstructured":"Denison\u00a0HJ, Curtis\u00a0EM, Clynes\u00a0MA et\u00a0al (2016) The incidence of sexually acquired reactive arthritis: a\u00a0systematic literature review. Clin Rheumatol 35(11):2639\u20132648","journal-title":"Clin Rheumatol"},{"key":"1594_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1521-6942(02)00104-3","volume":"17","author":"JSH Gaston","year":"2003","unstructured":"Gaston\u00a0JSH, Lillicrap\u00a0MS (2003) Arthritis associated with enteric infection. Best Pract Res Clin Rheumatol 17:219\u2013239","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1594_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/01.bor.0000126150.04251.f9","volume":"16","author":"H Zeidler","year":"2004","unstructured":"Zeidler\u00a0H, Kuipers\u00a0J, K\u00f6hler\u00a0L (2004) Chlamydia-induced arthritis. Curr Opin Rheumatol 16:380\u2013392","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"1594_CR17","doi-asserted-by":"publisher","first-page":"e16021","DOI":"10.1001\/jamapediatrics.2016.0217","volume":"170","author":"DB Horton","year":"2016","unstructured":"Horton\u00a0DB, Strom\u00a0BL, Putt\u00a0ME et\u00a0al (2016) Epidemiology of Clostridium difficile Infection-Associated Reactive Arthritis in Children: An Underdiagnosed, Potentially Morbid Condition. JAMA Pediatr 170(7):e16021","journal-title":"JAMA Pediatr"},{"issue":"1","key":"1594_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5455\/medarh.2015.69.42-45","volume":"69","author":"A Lahu","year":"2015","unstructured":"Lahu\u00a0A, Backa\u00a0T, Ismaili\u00a0J et\u00a0al (2015) Modes of presentation of reactive arthritis based on the affected joints. Med Arch 69(1):42\u201345","journal-title":"Med Arch"},{"issue":"4","key":"1594_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.idc.2006.09.004","volume":"20","author":"JD Carter","year":"2006","unstructured":"Carter\u00a0JD (2006) Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin North Am 20(4):827\u2013847","journal-title":"Infect Dis Clin North Am"},{"key":"1594_CR20","first-page":"325","volume":"27","author":"K Kaarela","year":"2009","unstructured":"Kaarela\u00a0K, J\u00e4ntti\u00a0JK, Kotaniemi\u00a0KM (2009) Similarity between chronic reactive arthritis and ankylosing spondylitis. A 32-35-year follow-up study. Clin Exp Rheumatol 27:325\u2013328","journal-title":"Clin Exp Rheumatol"},{"key":"1594_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.berh.2006.08.008","volume":"20","author":"M Rihl","year":"2006","unstructured":"Rihl\u00a0M, Klos\u00a0A, K\u00f6hler\u00a0L et\u00a0al (2006) Infection and musculoskeletal conditions: Reactive arthritis. Best Pract Res Clin Rheumatol 20:1119\u20131137","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1594_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4615-4857-7_29","volume":"455","author":"A Keat","year":"1999","unstructured":"Keat\u00a0A (1999) Reactive arthritis. Adv Exp Med Biol 455:201\u2013206","journal-title":"Adv Exp Med Biol"},{"key":"1594_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00393-004-0631-2","volume":"63","author":"H Haibel","year":"2004","unstructured":"Haibel\u00a0H, Rudwaleit\u00a0M, Sieper\u00a0J et\u00a0al (2004) Diagnostik der reaktiven Arthritis. Z\u00a0Rheumatol 63:211\u2013215","journal-title":"Z Rheumatol"},{"key":"1594_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00393-022-01253-x","volume":"81","author":"H Zeidler","year":"2022","unstructured":"Zeidler\u00a0H (2022) Geschichte der reaktiven Arthritis. Historische Meilensteine und Zukunft. Z\u00a0Rheumatol 81:692\u2013698","journal-title":"Z Rheumatol"},{"key":"1594_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0956462414533319","volume":"26","author":"D Taylor-Robinson","year":"2015","unstructured":"Taylor-Robinson\u00a0D, Keat\u00a0A (2015) Observations on Chlamydia trachomatis and other microbes in reactive arthritis. Int J STD Aids 26:139\u2013144","journal-title":"Int J STD Aids"},{"key":"1594_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11926-015-0559-3","volume":"18","author":"H Zeidler","year":"2016","unstructured":"Zeidler\u00a0H, Hudson\u00a0AP (2016) Causality of Chlamydiae in Arthritis and Spondyloarthritis: a\u00a0Plea for Increased Translational Research. Curr Rheumatol Rep 18:9","journal-title":"Curr Rheumatol Rep"},{"key":"1594_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J","volume":"41","author":"K Granfors","year":"1998","unstructured":"Granfors\u00a0K, Merilahti-Palo\u00a0R, Luukkainen\u00a0R et\u00a0al (1998) Persistence of yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 41:855\u2013862","journal-title":"Arthritis Rheum"},{"key":"1594_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1046\/j.1462-5822.2003.00346.x","volume":"6","author":"E Bohn","year":"2003","unstructured":"Bohn\u00a0E, Muller\u00a0S, Lauber\u00a0J et\u00a0al (2003) Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica. Cell Microbiol 6:129\u2013e141","journal-title":"Cell Microbiol"},{"key":"1594_CR29","unstructured":"(Empfehlung des Robert-Koch-Instituts, Merkbl\u00e4tter Chlamydiosen, Teil\u00a01): Erkrankungen durch Chlamydia trachomatis. www.rki.de. Zugegriffen: 3. Febr. 2024"},{"key":"1594_CR30","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/art.27394","volume":"62","author":"JD Carter","year":"2010","unstructured":"Carter\u00a0JD, Espinoza\u00a0LR, Inman\u00a0RD et\u00a0al (2010) Combination antibiotics as a\u00a0treatment for chronic Chlamydia-induced reactive arthritis: a\u00a0double-blind, placebo-controlled, prospective trial. Arthritis Rheum 62:1298\u20131307","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1594_CR31","first-page":"172","volume":"64","author":"CE Barber","year":"2012","unstructured":"Barber\u00a0CE, Kim\u00a0J, Inman\u00a0RD et\u00a0al (2012) A\u00a0Systematic Review and Meta-Analysis of Antibiotic Treatment for Reactive Arthritis. Arthritis Rheum 64(10):172","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1594_CR32","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3899\/jrheum.121192","volume":"40","author":"CE Barber","year":"2013","unstructured":"Barber\u00a0CE, Kim\u00a0J, Inman\u00a0RD et\u00a0al (2013) Antibiotics for treatment of reactive arthritis: a\u00a0systematic review and metaanalysis. J\u00a0Rheumatol 40(6):916\u2013928","journal-title":"J Rheumatol"},{"issue":"02","key":"1594_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/a-1754-8854","volume":"42","author":"M Rihl","year":"2022","unstructured":"Rihl\u00a0M, Kuipers\u00a0JG (2022) Reaktive Arthritis. Arthritis Rheuma 42(02):100\u2013105","journal-title":"Arthritis Rheuma"},{"key":"1594_CR34","unstructured":"https:\/\/dgrh.de\/Start\/Publikationen\/Empfehlungen\/Krankheitsbezogene-Therapie\/Lyme-Borreliose.html. Zugegriffen: 19. Apr. 2024"},{"key":"1594_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00393-022-01194-5","volume":"82","author":"N Ruffer","year":"2023","unstructured":"Ruffer\u00a0N, Holzer\u00a0M\u2011T, Gkanatsas\u00a0Y et\u00a0al (2023) Chronische Tropheryma-whippleiInfektion: Eine wichtige Differentialdiagnose der therapierefrakt\u00e4ren Polyarthritis. Z\u00a0Rheumatol 82:885\u2013891","journal-title":"Z Rheumatol"},{"issue":"3","key":"1594_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.idc.2022.03.006","volume":"36","author":"SL Arvikar","year":"2022","unstructured":"Arvikar\u00a0SL, Steere\u00a0AC (2022) Lyme Arthritis. Infect Dis Clin North Am 36(3):563\u2013577","journal-title":"Infect Dis Clin North Am"},{"key":"1594_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00296-013-2923-9","volume":"34","author":"S Nimmrich","year":"2014","unstructured":"Nimmrich\u00a0S, Becker\u00a0I, Horneff\u00a0G (2014) Intraarticular corticosteroids in refractory childhood Lyme arthritis. Rheumatol Int 34:987\u2013994","journal-title":"Rheumatol Int"},{"issue":"12","key":"1594_CR38","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/art.1780391210","volume":"39","author":"DO Clegg","year":"1996","unstructured":"Clegg\u00a0DO, Reda\u00a0DJ, Mejias\u00a0E et\u00a0al (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2013\u20132020","journal-title":"Arthritis Rheum"},{"key":"1594_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00063030-200013010-00003","volume":"13","author":"M Rudwaleit","year":"2000","unstructured":"Rudwaleit\u00a0M, Braun\u00a0J, Sieper\u00a0J (2000) Treatment of reactive arthritis: a\u00a0practical guide. BioDrugs 13:21\u201328","journal-title":"BioDrugs"},{"key":"1594_CR40","doi-asserted-by":"crossref","unstructured":"Zeng H, Luo B, Zhang Y et\u00a0al (2020) Treatment of reactive arthritis with biological agents: a\u00a0review. Biosci Rep 40(2)","DOI":"10.1042\/BSR20191927"},{"issue":"7","key":"1594_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11926-020-00904-9","volume":"22","author":"D Wendling","year":"2020","unstructured":"Wendling\u00a0D, Prati\u00a0C, Chouk\u00a0M et\u00a0al (2020) Reactive Arthritis: Treatment Challenges and Future Perspectives. Curr Rheumatol Rep 22(7):29","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"1594_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/ijdvl.IJDVL_519_18","volume":"87","author":"V Gupta","year":"2021","unstructured":"Gupta\u00a0V, Mohta\u00a0P, Sharma\u00a0VK, Neena Khanna\u00a0N (2021) A\u00a0retrospective case series of 12\u00a0patients with chronic reactive arthritis with emphasis on treatment outcome with biologics. Indian J Dermatol Venereol Leprol 87(2):227\u2013234","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"1594_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/mrcr\/rxab014","volume":"6","author":"P Padhan","year":"2022","unstructured":"Padhan\u00a0P, Maikap\u00a0D (2022) Secukinumab therapy in reactive arthritis: Report of two cases. Mod Rheumatol Case Rep 6(1):22\u201324","journal-title":"Mod Rheumatol Case Rep"},{"issue":"2","key":"1594_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/mrcr\/rxab029","volume":"6","author":"D Maikap","year":"2022","unstructured":"Maikap\u00a0D, Padhan\u00a0P (2022) Successful use of tofacitinib in reactive arthritis refractory to conventional therapies\u2014a\u00a0case series. Mod Rheumatol Case Rep 6(2):167\u2013170","journal-title":"Mod Rheumatol Case Rep"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01594-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01594-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01594-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T13:02:32Z","timestamp":1745931752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01594-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1594"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01594-9","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"22 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Beratungs- oder Vortragst\u00e4tigkeit in den letzten 3\u00a0Jahren: M.\u00a0Rihl f\u00fcr Celltrion, Galapagos, Novartis, Sanofi, UCB. J.G.\u00a0Kuipers f\u00fcr AbbVie, Biogen, Boehringer-Ingelheim, Celltrion, CSL Vifor, Fresenius-Kabi, GSK, Hexal, Janssen, Lilly, Novartis, Pfizer, Roche, Takeda, UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}